LobbyingAmerican Association of Orthopaedic Surgeons lobbying by quarter
American Association of Orthopaedic Surgeons's latest lobbying report covers Q2 2026, at $400K. The four quarters Q4 2025–Q3 2026 total $1.2M. Its first report covers Q4 2022; the issues it reports most are Labor Issues/Antitrust/Workplace and Medicare/Medicaid.
American Association of Orthopaedic Surgeons
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.2M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $326.5K | 1 |
| Q1 2023 | $431.4K | 1 |
| Q2 2023 | $477.2K | 1 |
| Q3 2023 | $307.3K | 1 |
| Q4 2023 | $484.8K | 1 |
| Q1 2024 | $424.7K | 1 |
| Q2 2024 | $433.8K | 1 |
| Q3 2024 | $393.6K | 1 |
| Q4 2024 | $518.7K | 1 |
| Q1 2025 | $519.3K | 1 |
| Q2 2025 | $516.2K | 1 |
| Q3 2025 | $458.4K | 1 |
| Q4 2025 | $376.8K | 1 |
| Q1 2026 | $465K | 1 |
| Q2 2026 | $400K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Labor, antitrust and workplace$1.9M · 15 reports
- Medicare and Medicaid$1.9M · 15 reports
- Insurance$949.5K · 9 reports
- Medical research and clinical labs$949.5K · 9 reports
- Budget and appropriations$738.8K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAmerican Association of Orthopaedic Surgeons | $6.5M | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | In-house | $400K |
| 04/21for Q1 | In-house | $465K |
| 01/20for Q4 2025 | In-house | $376.8K |
| 25/10/20for Q3 2025 | In-house | $458.4K |
| 25/07/18for Q2 2025 | In-house | $516.2K |
| 25/04/18for Q1 2025 | In-house | $519.3K |
| 25/01/17for Q4 2024 | In-house | $518.7K |
| 24/10/18for Q3 2024 | In-house | $393.6K |
| 24/09/12for Q1 2024 | In-house | $424.7K |
| 24/07/15for Q2 2024 | In-house | $433.8K |
| 24/04/19for Q1 2024 | In-house | $424.7K |
| 24/01/19for Q4 2023 | In-house | $484.8K |
| 23/10/18for Q3 2023 | In-house | $307.3K |
| 23/07/19for Q2 2023 | In-house | $477.2K |
| 23/06/27for Q4 2022 | In-house | $326.5K |
| 23/04/17for Q1 2023 | In-house | $431.4K |
| 23/01/20for Q4 2022 | In-house | $326.5K |